Literature DB >> 12668685

Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis.

Tavan Janvilisri1, Henrietta Venter, Sanjay Shahi, Galya Reuter, Lekshmy Balakrishnan, Hendrik W van Veen.   

Abstract

The human breast cancer resistance protein (BCRP, also know as ABCG2, MXR, or ABCP) is one of the more recently discovered ATP-binding cassette (ABC) transporters that confer resistance on cancer cells by mediating multidrug efflux. In the present study, we have obtained functional expression of human BCRP in the Gram-positive bacterium Lactococcus lactis. BCRP expression conferred multidrug resistance on the lactococcal cells, which was based on ATP-dependent drug extrusion. BCRP-mediated ATPase and drug transport activities were inhibited by the BCRP-specific modulator fumitremorgin C. To our knowledge these data represent the first example of the functional expression of a mammalian ABC half-transporter in bacteria. Although members of the ABCG subfamily (such as ABCG1 and ABCG5/8) have been implicated in the transport of sterols, such a role has not yet been established for BCRP. Interestingly, the BCRP-associated ATPase activity in L. lactis was significantly stimulated by (i) sterols including cholesterol and estradiol, (ii) natural steroids such as progesterone and testosterone, and (iii) the anti-estrogen anticancer drug tamoxifen. In addition, BCRP mediated the efflux of [3H]estradiol from lactococcal cells. Our findings suggest that BCRP may play a role in the transport of sterols in human, in addition to its ability to transport multiple drugs and toxins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668685     DOI: 10.1074/jbc.M301358200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Recombinant synthesis of human ABCG2 expressed in the yeast Saccharomyces cerevisiae: an experimental methodological study.

Authors:  Anna Jacobs; Dana Emmert; Svenja Wieschrath; Christine A Hrycyna; Michael Wiese
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

2.  Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution.

Authors:  Jin Wang; Fang Sun; Da-wei Zhang; Yongming Ma; Fang Xu; Jitendra D Belani; Jonathan C Cohen; Helen H Hobbs; Xiao-Song Xie
Journal:  J Biol Chem       Date:  2006-07-25       Impact factor: 5.157

Review 3.  Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Suresh V Ambudkar
Journal:  Curr Mol Pharmacol       Date:  2008-06       Impact factor: 3.339

4.  Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics.

Authors:  Supeecha Kumkate; Supatra Chunchob; Tavan Janvilisri
Journal:  Mol Cell Biochem       Date:  2008-06-10       Impact factor: 3.396

5.  ATP-binding cassette transporter G2 activity in the bovine spermatozoa is modulated along the epididymal duct and at ejaculation.

Authors:  Julieta Caballero; Gilles Frenette; Olivier D'Amours; Maurice Dufour; Richard Oko; Robert Sullivan
Journal:  Biol Reprod       Date:  2012-06-14       Impact factor: 4.285

6.  Deregulated hepatic metabolism exacerbates impaired testosterone production in Mrp4-deficient mice.

Authors:  Jessica A Morgan; Satish B Cheepala; Yao Wang; Geoff Neale; Masashi Adachi; Deepa Nachagari; Mark Leggas; Wenchen Zhao; Kelli Boyd; Raman Venkataramanan; John D Schuetz
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 7.  ABCG transporters: structure, substrate specificities and physiological roles : a brief overview.

Authors:  Saroj Velamakanni; Shen L Wei; Tavan Janvilisri; Hendrik W van Veen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

8.  ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate.

Authors:  Grinu Mathew; Earl A Timm; Paula Sotomayor; Alejandro Godoy; Viviana P Montecinos; Gary J Smith; Wendy J Huss
Journal:  Cell Cycle       Date:  2009-04-30       Impact factor: 4.534

9.  Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.

Authors:  Yue-xian Hou; Chang-Zhong Li; Kanagaraj Palaniyandi; Paul M Magtibay; Laszlo Homolya; Balazs Sarkadi; Xiu-bao Chang
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

10.  BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.

Authors:  J M Day; P A Foster; H J Tutill; S P Newman; Y T Ho; M P Leese; B V L Potter; M J Reed; A Purohit
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.